Following curcumin (33) treatment of leiomyosarcoma SK-UT-1 and SKN cells, the expression of LC3B-II increases, SQSTM1 levels decrease and the MAPK1-MAPK3 pathway is activated [223]. Here, MAPK1 is linked to leiomyosarcoma.